GPT and myeloid sarcoma: The prevalence of NAFLD having elevation of ALT was higher in the MS group than in the Pre-MS group and Non-MS group (p < 0.001 and p < 0.001, respectively), and the prevalence of NAFLD having elevation of ALT was higher in Pre-MS group than in the Non-MS group (p <0.001).